Agalsidase beta slows the progression of renal outcomes in Fabry disease patients: A systematic literature review

被引：0
|
作者：
Fan, Qi [1 ]
Wilson, Florence [2 ]
DasMahapatra, Pronabesh [1 ]
Maski, Manish [1 ]
Hariri, Ali [1 ]
Adeyemi, Adekemi [2 ]
Wu, Ping [2 ]
Hamed, Alaa [1 ]
机构：
[1] Sanofi Genzyme, Cambridge, MA USA
[2] Precis Xtract, Vancouver, BC, Canada
来源：
MOLECULAR GENETICS AND METABOLISM | 2020年 / 129卷 / 02期
关键词：
D O I：
10.1016/j.ymgme.2019.11.124
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
115
引用
收藏
页码：S55 / S55
页数：1
相关论文
共 50 条
  • [1] Agalsidase beta stabilizes cardiac outcomes in Fabry disease patients: A systematic literature review
    DasMahapatra, Pronabesh
    Wilson, Florence
    Fan, Qi
    Maski, Manish
    Hariri, Ali
    Adeyemi, Adekemi
    Wu, Ping
    Hamed, Alaa
    MOLECULAR GENETICS AND METABOLISM, 2020, 129 (02) : S45 - S46
  • [2] Agalsidase beta slows the progression of advanced Fabry's disease
    Nature Clinical Practice Neurology, 2007, 3 (4): : 187 - 187
  • [3] Agalsidase beta slows the progression of advanced Fabry's disease
    Nature Clinical Practice Nephrology, 2007, 3 (4): : 181 - 181
  • [4] Agalsidase beta slows the progression of advanced Fabry's disease
    Nature Clinical Practice Cardiovascular Medicine, 2007, 4 (5): : 239 - 239
  • [5] A systematic literature review to evaluate the cardiac and cerebrovascular outcomes of patients with Fabry disease treated with agalsidase Beta
    Oudit, Gavin Y.
    Dasmahapatra, Pronabesh
    Lyn, Nicole
    Wilson, Florence R.
    Adeyemi, Adekemi
    Lee, Chae Sung
    Crespo, Ana
    Namdar, Mehdi
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2025, 11
  • [6] Agalsidase Alfa Slows the Decline in Renal Function in Patients with Fabry Disease
    Feriozzi, Sandro
    Schwarting, Andreas
    Sunder-Plassmann, Gere
    West, Michael
    Cybulla, Markus
    AMERICAN JOURNAL OF NEPHROLOGY, 2009, 29 (05) : 353 - 361
  • [7] Switch to agalsidase alfa after shortage of agalsidase beta in Fabry disease: a systematic review and meta-analysis of the literature
    Pisani, Antonio
    Bruzzese, Dario
    Sabbatini, Massimo
    Spinelli, Letizia
    Imbriaco, Massimo
    Riccio, Eleonora
    GENETICS IN MEDICINE, 2017, 19 (03) : 275 - 282
  • [8] A COST ANALYSIS ON RENAL DISEASE PROGRESSION OF FABRY DISEASE PATIENTS TREATED WITH AGALSIDASE BETA BASED ON RENAL DISEASE STAGE IN COLOMBIA
    Londono, S.
    Ossa, M. E.
    Solano, D. A.
    VALUE IN HEALTH, 2023, 26 (06) : S112 - S112
  • [9] CARDIAC OUTCOMES OF AGALSIDASE BETA TREATMENT FOR FABRY DISEASE: ANALYSIS OF CARDIOVASCULAR DISEASE PROGRESSION IN MEN ENROLLED IN THE FABRY REGISTRY
    Germain, D. P.
    Abiose, A.
    Patel, M. R.
    Weidemann, F.
    Benistan, K.
    Waldek, S.
    Strotmann, J.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2012, 35 : S92 - S92
  • [10] AGALSIDASE ALFA AND AGALSIDASE BETA FOR TREATMENT OF FABRY DISEASE
    Costa, M. G.
    Santos, M.
    Senna, K.
    VALUE IN HEALTH, 2018, 21 : S439 - S440
12345